You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》諾誠健華(09969.HK)暗盤高開逾15%報10.32元
阿思達克 03-20 17:28
根據輝立交易平台顯示,下周一(23日)明天掛牌的諾誠健華-B(09969.HK)暗盤高開逾15%報10.32元,高低見10.66元/9.6元,現造10.22元,較上市價8.95元,高14%,成交1,410萬股。

諾誠健華為內地生物醫藥公司。是次來港上市共發售2.5億股,並已引入12名基石投資者合共認購1.25162億股;其中10%公開發售獲近300倍超購,已啟動回撥機制佔比增至50%,認購一手中籤率25%;股份以招股範圍(8.18-8.95元)上限定價,料集資淨額20.93億元,主要用作核心藥物奧布替尼於內地及美國進行臨床試驗和商業化等工作提供資金、為兩個臨床階段候選產品提供資金、為公司管線中6種IND(臨床研究用新藥或臨床研究用新藥申請)準備階段候選藥物研發提供資金等。上市聯席保薦人分別為大摩及高盛。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account